U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H14O4
Molecular Weight 282.2907
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VADIMEZAN

SMILES

CC1=CC=C2C(=O)C3=C(OC2=C1C)C(CC(O)=O)=CC=C3

InChI

InChIKey=XGOYIMQSIKSOBS-UHFFFAOYSA-N
InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)

HIDE SMILES / InChI
Molecular Formula C17H14O4
Molecular Weight 282.2907
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:02:53 UTC 2023
Edited
by admin
on Fri Dec 15 16:02:53 UTC 2023
Record UNII
0829J8133H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VADIMEZAN
INN   WHO-DD  
INN  
Official Name English
2-(5,6-DIMETHYL-9-OXO-9H-XANTHEN-4-YL)ACETIC ACID
Systematic Name English
Vadimezan [WHO-DD]
Common Name English
9H-XANTHENE-4-ACETIC ACID, 5,6-DIMETHYL-9-OXO-
Systematic Name English
vadimezan [INN]
Common Name English
DMXAA
Code English
AS-1404
Code English
ASA-404
Code English
ASA404
Code English
NSC-640488
Code English
Classification Tree Code System Code
NCI_THESAURUS C306
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
Code System Code Type Description
SMS_ID
100000151799
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
CHEBI
75934
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
PUBCHEM
123964
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
DRUG BANK
DB06235
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
NCI_THESAURUS
C2504
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
NSC
640488
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
INN
8918
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
WIKIPEDIA
Vadimezan
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
EPA CompTox
DTXSID2040949
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
MESH
C066668
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
EVMPD
SUB126221
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
CAS
117570-53-3
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
FDA UNII
0829J8133H
Created by admin on Fri Dec 15 16:02:53 UTC 2023 , Edited by admin on Fri Dec 15 16:02:53 UTC 2023
PRIMARY
Related Record Type Details
TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (PLASMA DERIVED, SOLUBLE FORM)
TARGET -> ACTIVATOR
Structure of VADIMEZAN SODIUM
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of VADIMEZAN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966